Efficient Enzymatic Glycan Engineering of Extracellular Vesicles Using Nanomaterial-Interfaced Microfluidics
Source abstract
Abstract
Extracellular vesicles (EVs) present a promising modality for numerous biological and medical applications, including therapeutics. Developing facile methods to engineer EVs is essential to meeting the rapidly expanding demand for various functionalized EVs in these applications. Herein, we developed a technology that integrates enzymatic glycoengineering and microfluidics for effective EV functionalization. This method builds on a 3D nanostructured microfluidic device to streamline a multiple-step EV engineering process, which involves a step of enzymatic reaction to install azido-sialic acid residues to glycans on EVs using a sialyltransferase and an azide-tagged sialyl donor followed by the attachment of various functionalities, such as biotin and fluorescent labels, to the resulting azido-glycans on EVs through a biocompatible click reaction. Compared to traditional EV engineering methods, we show that our technology improves the efficiency of EV glycoengineering while simplifying and expediting the workflow. Furthermore, we demonstrated the applicability of this technology to EVs derived from the cell lines of different cancer types, including A549, PC3, and COLO-1 cells. Overall, this EV engineering technology could provide a potentially useful tool for broad applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · Electrospun Nanofibers in Biomedical Applications · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, University of Florida, Gainesville, Florida 32611, United States
University of Florida Health Cancer Center, Gainesville, Florida 32610, United States
J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, Florida 32611, United States
Funding
National Cancer Institute · National Institute of General Medical Sciences
References (82)
Show source-provided references
1. 10.1080/20013078.2018.153575010.1080/20013078.2018.1535750 ↗
2. 10.1038/s41556-018-0250-910.1038/s41556-018-0250-9 ↗
3. 10.1186/s12964-021-00730-110.1186/s12964-021-00730-1 ↗
4. 10.1021/acs.bioconjchem.9b0008510.1021/acs.bioconjchem.9b00085 ↗
5. 10.1126/science.aau697710.1126/science.aau6977 ↗
6. 10.2147/IJN.S28189010.2147/IJN.S281890 ↗
7. 10.1111/febs.1555810.1111/febs.15558 ↗
8. 10.1186/s12943-020-01278-310.1186/s12943-020-01278-3 ↗
9. 10.1039/C9BM00580C10.1039/C9BM00580C ↗
10. 10.1021/jacs.8b1004710.1021/jacs.8b10047 ↗
11. 10.7150/thno.5257010.7150/thno.52570 ↗
12. 10.1039/D0TB00744G10.1039/D0TB00744G ↗
13. 10.1021/acsnano.6b0760710.1021/acsnano.6b07607 ↗
14. 10.1016/j.jconrel.2020.07.04210.1016/j.jconrel.2020.07.042 ↗
15. 10.1016/j.addr.2021.03.02010.1016/j.addr.2021.03.020 ↗
16. 10.1016/j.procbio.2016.07.00210.1016/j.procbio.2016.07.002 ↗
17. 10.1038/nbt.180710.1038/nbt.1807 ↗
18. 10.1016/j.jbiotec.2013.03.01310.1016/j.jbiotec.2013.03.013 ↗
19. 10.1016/j.biomaterials.2013.11.08310.1016/j.biomaterials.2013.11.083 ↗
20. 10.1038/ncomms802910.1038/ncomms8029 ↗
21. 10.1016/j.bbrc.2016.02.05810.1016/j.bbrc.2016.02.058 ↗
22. 10.3402/jev.v5.3105310.3402/jev.v5.31053 ↗
23. 10.1021/acs.molpharmaceut.7b0076010.1021/acs.molpharmaceut.7b00760 ↗
24. 10.1002/jev2.1229010.1002/jev2.12290 ↗
25. 10.1371/journal.pone.014186010.1371/journal.pone.0141860 ↗
26. 10.1016/j.bbagen.2018.02.00110.1016/j.bbagen.2018.02.001 ↗
27. 10.1021/acs.bioconjchem.0c0021610.1021/acs.bioconjchem.0c00216 ↗
28. 10.1126/sciadv.abe008310.1126/sciadv.abe0083 ↗
29. 10.1021/acsnano.5b0693910.1021/acsnano.5b06939 ↗
30. 10.1021/acssensors.9b0186910.1021/acssensors.9b01869 ↗
31. 10.1038/s41598-019-50412-910.1038/s41598-019-50412-9 ↗
32. 10.1021/bc500291r10.1021/bc500291r ↗
33. 10.1016/j.jconrel.2015.01.02710.1016/j.jconrel.2015.01.027 ↗
34. 10.1002/mabi.20190004210.1002/mabi.201900042 ↗
35. 10.1039/D1AN02226A10.1039/D1AN02226A ↗
36. 10.1038/s41467-019-09608-w10.1038/s41467-019-09608-w ↗
37. 10.1021/acscentsci.7b0057310.1021/acscentsci.7b00573 ↗
38. 10.1093/glycob/cwx09510.1093/glycob/cwx095 ↗
39. 10.1074/jbc.M115.70036910.1074/jbc.M115.700369 ↗
40. 10.1002/anie.20130709510.1002/anie.201307095 ↗
41. 10.1021/ja211312u10.1021/ja211312u ↗
42. 10.1021/ja804614w10.1021/ja804614w ↗
43. 10.1038/s41598-019-48499-110.1038/s41598-019-48499-1 ↗
44. 10.1080/20013078.2018.144298510.1080/20013078.2018.1442985 ↗
45. 10.1021/pr200434y10.1021/pr200434y ↗
46. 10.1038/nchembio.15110.1038/nchembio.151 ↗
47. 10.3390/cells909194610.3390/cells9091946 ↗
48. 10.1002/pmic.20180014910.1002/pmic.201800149 ↗
49. 10.1016/j.molimm.2021.04.01710.1016/j.molimm.2021.04.017 ↗
50. 10.21873/cgp.2001510.21873/cgp.20015 ↗
51. 10.1111/imr.1252610.1111/imr.12526 ↗
52. 10.1002/ctm2.20410.1002/ctm2.204 ↗
53. 10.3390/ijms2006138910.3390/ijms20061389 ↗
54. 10.1002/smtd.20210078510.1002/smtd.202100785 ↗
55. 10.1039/D1LC00443C10.1039/D1LC00443C ↗
56. 10.1021/acs.analchem.1c0069310.1021/acs.analchem.1c00693 ↗
57. 10.1039/C8LC01279B10.1039/C8LC01279B ↗
58. 10.1021/acschembio.1c0027310.1021/acschembio.1c00273 ↗
59. 10.1038/nsmb72010.1038/nsmb720 ↗
60. 10.1074/jbc.M111.26117210.1074/jbc.M111.261172 ↗
61. 10.1093/glycob/cwn04710.1093/glycob/cwn047 ↗
62. 10.1021/ja907750r10.1021/ja907750r ↗
63. 10.2147/IJN.S26449810.2147/IJN.S264498 ↗
64. 10.3402/jev.v2i0.2092010.3402/jev.v2i0.20920 ↗
65. 10.1155/2015/52481710.1155/2015/524817 ↗
66. 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R ↗
67. 10.1016/j.bbamcr.2008.01.03010.1016/j.bbamcr.2008.01.030 ↗
68. 10.1002/smll.20190360010.1002/smll.201903600 ↗
69. 10.1016/j.transci.2016.07.00910.1016/j.transci.2016.07.009 ↗
70. 10.1002/jev2.1220010.1002/jev2.12200 ↗
71. 10.1016/0003-9861(92)90111-910.1016/0003-9861(92)90111-9 ↗
72. 10.1016/S0956-5663(99)00044-510.1016/S0956-5663(99)00044-5 ↗
73. 10.1002/bit.1076010.1002/bit.10760 ↗
74. 10.1016/j.jprot.2012.03.05010.1016/j.jprot.2012.03.050 ↗
75. 10.1016/j.carres.2005.06.00810.1016/j.carres.2005.06.008 ↗
76. 10.1080/01478885.2019.164698410.1080/01478885.2019.1646984 ↗
77. 10.1007/s10719-020-09940-010.1007/s10719-020-09940-0 ↗
78. 10.2174/092986652166614062611123710.2174/0929866521666140626111237 ↗
79. 10.1038/s41467-024-46557-510.1038/s41467-024-46557-5 ↗
80. 10.1126/scitranslmed.aaz287810.1126/scitranslmed.aaz2878 ↗
81. 10.1021/accountsmr.1c0027610.1021/accountsmr.1c00276 ↗
82. 10.1038/s41592-020-01034-x10.1038/s41592-020-01034-x ↗